BioSpace News Archive

Tyber Medical, a leader in the medical device industry, is pleased to announce that it has received.

JanOne, the biopharmaceutical company focused on developing non-addicting painkillers and novel treatments for the causes of pain, will participate in investor sessions at the Dawson James Securities 8th Annual Investment Conference in Jupiter, Florida.

Breakthrough Properties, a premier global life sciences real estate developer, announced that it has reached an agreement with Neogene Therapeutics to develop its new European headquarters within the campus of the Amsterdam University Medical Center (Amsterdam UMC), one of Europe’s leading medical institutions.

C2N Diagnostics is marking World Alzheimer’s Day by highlighting the growing international availability of the PrecivityAD2 blood test, a clinical care assay that helps healthcare providers identify amyloid plaques in the brain, which are recognized as key indicators of Alzheimer’s disease.

Cingulate Inc. announced that Chairman & CEO, Shane J. Schaffer, will be presenting a company overview at the 16th annual Main Event on Wednesday, October 4th at 02:30 PM PT at the Luxe Sunset Boulevard Hotel.

Lipogems announced that there are now 140 peer reviewed publications supporting Lipogems’ MicroFat with 5 years of follow up in orthopaedics.

Humacyte, Inc. announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, and Dale Sander, Chief Financial Officer, will present at the Cantor Global Healthcare Conference, in New York, NY on September 28, 2023.

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) today announced that its Chief Executive Officer, Robert Foster, PharmD, PhD, will participate in a panel discussion during the 2023 Cantor Global Healthcare Conference on Wednesday, September 27, 2023 at 9:45 a.m. ET in NYC.

Tenaya Therapeutics, Inc. (NASDAQ: TNYA) announced today that poster presentations related to its TN-201 and TN-301 programs will be presented at the 2023 Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions taking place October 6, 2023, and at the Heart Failure Society of America (HFSA) Annual Scientific Meeting occurring October 6-9, 2023.

Scilex Holding Company announced the consummation of the previously announced purchase of securities from Sorrento Therapeutics, Inc..